The goal of this study is to assess whether DCE-MRI and IVIM-DWI can be used to predict response of hepatocellular carcinoma (HCC) to 90Yttrium radioembolization (RE). In a preliminary cohort, significant changes were observed in both DCE-MRI and IVIM-DWI parameters at 6 weeks after treatment, which suggest that both techniques are sensitive to treatment effects of RE to HCC tissue. The exact utility of the DCE-MRI and IVIM-DWI parameters will be tested in a larger cohort.
This abstract and the presentation materials are available to members only; a login is required.